Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.43 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | GGT1 | P19440 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 10/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6676701 | 1.00 | FOLH1 (0.49) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| Hydrochloric Acid SCHEMBL15923088 | 0.98 | FOLH1 (0.47) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| Acetic Acid SCHEMBL268741 | 0.95 | FOLH1 (0.45) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL232126 | 0.95 | FOLH1 (0.42) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL3433410 | 0.95 | FOLH1 (0.42) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL27799398 | 0.95 | FOLH1 (0.42) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| Hydrochloric Acid SCHEMBL15923983 | 0.93 | FOLH1 (0.41) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL861645 | 0.83 | FOLH1 (0.49) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL861646 | 0.83 | FOLH1 (0.49) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL29666181 | 0.83 | FOLH1 (0.49) | FOLH1GSRRNPEPSLC6A5MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088150-B2 | Device for disc shunt implantation and peri-shunt injection | ALEEVA MEDICAL INC. (US) | 2012-01-03 | — | — | US | claimed |
| US-20090325858-A1 | Reduction of Zinc-Induced Neurotoxic Injury By Blockade of Nitric Oxide Synthesis | ANDRO DIAGNOSTICS, INC. (US) | 2009-12-31 | — | — | US | claimed |
| US-20090198248-A1 | Device for disc shunt implantation and peri-shunt injection | YEUNG JEFFREY E | 2009-08-06 | — | — | US | claimed |
| WO-2008080194-A1 | PAIN-RELIEVING COMPOSITIONS AND USES THEREFOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2008-07-10 | — | — | WO | claimed |
| EP-1534313-A4 | OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD | OMEROS CORP (US) | 2008-06-25 | — | — | EP | claimed |
| JP-2007502327-A | — | — | 2007-02-08 | — | — | JP | claimed |
| WO-2006084322-A1 | TREATMENT METHOD FOR MODIFYING TISSUE PASSIVE ELECTRICAL CONDUCTANCE | MCLACHLAN CRAIG STEVEN (AU) | 2006-08-17 | — | — | WO | claimed |
| EP-1631266-A2 | A METHOD OF TREATING DEGENERATIVE DISC DISEASE | DePuy Spine, Inc. (US) | 2006-03-08 | — | — | EP | claimed |
| WO-2005123130-A2 | IMPROVED TREATMENTS OF RHEUMATIC AND ARTHRITIC DISEASES COMPRISING COMBINATIONS OF A 5-LIPOXYGENASE INHIBITOR | OSTEOLOGIX A/S (DK) | 2005-12-29 | — | — | WO | claimed |
| WO-2005105065-A2 | THIAZOLE-BASED NITRIC OXIDE DONORS FOR TREATING INFLAMMATORY BOWEL DISEASES | RENOPHARM LTD. (IL) | 2005-11-10 | — | — | WO | claimed |
| WO-2004084827-A2 | REDUCTION OF ZINC-INDUCED NEUROTOXIC INJURY BY BLOCKADE OF NITRIC OXIDE SYNTHESIS | NEUROBIOTEX, INC. (US) | 2004-10-07 | — | — | WO | claimed |
| WO-2004010894-A2 | OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD | OMEROS CORPORATION (US) | 2004-02-05 | — | — | WO | claimed |
| US-6653350-B1 | Modulating interleukin-1 beta levels with n-iminoethyl-lysine | G.D. SEARLE & CO. | 2003-11-25 | — | — | US | claimed |
| WO-2003074082-A1 | FORMULATIONS AND METHODS OF USING NITRIC OXIDE MIMETICS IN CANCER TREATMENT | CELLEGY PHARMACEUTICALS, INC. (CA) | 2003-09-12 | — | — | WO | claimed |
| EP-0966286-B1 | ATTENUATION OF OPIOID TOLERANCE BY INHIBITING INDUCIBLE NITRIC OXIDE SYNTHASE PATHWAYS IN THE TREATMENT OF PAIN | SEARLE & CO (US) | 2003-07-30 | — | — | EP | claimed |
| US-20020119952-A1 | Composition and method of treating arthritis | ADVANCED MEDICAL INSTRUMENTS | 2002-08-29 | — | — | US | claimed |
| EP-0866695-A4 | COMBINATIONAL THERAPEUTIC METHODS EMPLOYING NITRIC OXIDE SCAVENGERS | MEDINOX INC (US) | 2001-05-09 | — | — | EP | claimed |
| EP-0866695-A1 | COMBINATIONAL THERAPEUTIC METHODS EMPLOYING NITRIC OXIDE SCAVENGERS | Medinox, Inc. (US) | 1998-09-30 | — | — | EP | claimed |
| WO-1997032585-A1 | COMBINATIONAL THERAPEUTIC METHODS EMPLOYING NITRIC OXIDE SCAVENGERS AND COMPOSITIONS USEFUL THEREFOR | MEDINOX, INC. (US) | 1997-09-12 | — | — | WO | claimed |
| WO-1997018805-A1 | COMBINATIONAL THERAPEUTIC METHODS EMPLOYING NITRIC OXIDE SCAVENGERS | MEDINOX, INC. (US) | 1997-05-29 | — | — | WO | claimed |